WHO launches global guidelines on diabetes during pregnancy on World Diabetes Day

The World Health Organization (WHO) today released its first global guidelines for the management of diabetes during pregnancy, a condition affecting about one in six pregnancies – or 21 million women annually. The new recommendations provide a critical roadmap to tackle this growing health challenge and prevent serious complications for both women and their children.

Understanding the nuances of endocrinology requires a comprehensive approach that considers both individual circumstances and broader medical research. Medical professionals emphasize the importance of personalized care and evidence-based practices when addressing health concerns.

Recent studies have shed light on various aspects of endocrinology, providing new insights that can help individuals make informed decisions about their health. It's essential to consult with qualified healthcare providers who can offer guidance tailored to your specific needs and medical history.

When considering treatment options or lifestyle changes related to endocrinology, it's important to weigh the potential benefits against any risks. Open communication with your healthcare team ensures that you receive the most appropriate care and support throughout your health journey.

Preventive measures and early intervention play crucial roles in maintaining optimal health outcomes. Staying informed about the latest research and recommendations in endocrinology can empower you to take proactive steps toward better health and well-being.

The World Health Organization (WHO) today released its first global guidelines for the management of diabetes during pregnancy, a condition affecting about one in six pregnancies – or 21 million women annually. The new recommendations provide a critical roadmap to tackle this growing health challenge and prevent serious complications for both women and their children.

Diabetes in pregnancy, if not managed effectively, significantly increases the risk of life-threatening conditions such as pre-eclampsia, stillbirth, and birth injuries. It also has long-term consequences, elevating the lifetime risk of type 2 diabetes and cardiometabolic diseases for both mother and child. The burden is greatest in low- and middle-income countries, where access to specialized care and resources may be limited, yet the need is most acute.

“WHO has long had guidance on diabetes and guidance on pregnancy, but this is the first time we have issued a specific standard of care for managing diabetes during pregnancy,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “These guidelines are grounded in the realities of women’s lives and health needs, and provide clear, evidence-based strategies to deliver high-quality care for every woman, everywhere.”

The guidelines include 27 key recommendations, emphasizing:

The release of these guidelines marks a pivotal step in strengthening maternal health and combating noncommunicable diseases (NCDs). They underscore the importance of integrating diabetes care into routine antenatal services and ensuring equitable access to essential medicines and technologies.